XML 28 R17.htm IDEA: XBRL DOCUMENT v3.4.0.3
11. Segment Information
 3 Months Ended
Mar. 31, 2016
Segment Reporting [Abstract]  
Segment Information
11.    SEGMENT INFORMATION

Information regarding industry segments for the three months ended March 31, 2016 and 2015 is as follows (in millions):
 
 
Life
Science
 
Clinical
Diagnostics
 
Other
Operations
 
 
 
 
 
 
 
Segment net sales 
2016
$
165.9

 
$
301.7

 
$
3.6

 
2015
$
155.9

 
$
313.6

 
$
3.3

 
 
 
 
 
 
 
Segment net (loss) profit
2016
$
(3.3
)
 
$
24.8

 
$
0.3

 
2015
$
(2.4
)
 
$
35.2

 
$
(0.1
)

Segment results are presented in the same manner as we present our operations internally to make operating decisions and assess performance.  Net corporate operating, interest and other expense for segment results consists of receipts and expenditures that are not the primary responsibility of segment operating management and therefore are not allocated to the segments for performance assessment by our chief operating decision maker.  Interest expense is charged to segments based on the carrying amount of inventory and receivables employed by that segment.  The following reconciles total segment profit to consolidated income before taxes (in millions):

 
Three Months Ended
 
March 31,
 
2016
 
2015
Total segment profit
$
21.8

 
$
32.7

Foreign currency exchange losses, net
(1.1
)
 
(3.8
)
Net corporate operating, interest and other expense not allocated to segments
(1.7
)
 
(3.4
)
Other income (expense), net
1.2

 
1.2

Consolidated income before income taxes
$
20.2

 
$
26.7